In vitro activity of tedizolid against the Mycobacterium abscessus complex - Archive ouverte HAL Access content directly
Journal Articles Diagnostic Microbiology and Infectious Disease Year : 2018

In vitro activity of tedizolid against the Mycobacterium abscessus complex

(1, 2, 3, 4) , (2, 3, 4) , (5, 6, 7) , (5, 6, 7) , (5, 6, 7) , (2, 3, 4) , (2, 3, 4) , (8, 2, 3, 4, 9)
1
2
3
4
5
6
7
8
9

Abstract

Infections due to Mycobacterium abscessus carry a poor prognosis since this rapidly growing mycobacterium is intrinsically resistant to most antibiotics. Here, we evaluate the in vitro activity of the new oxazolidinone tedizolid against a collection of 44M. abscessus clinical isolates. The MIC50s and MIC90s of tedizolid (2 and 8μg/mL, respectively) were 2- to 16-fold lower than those of linezolid. There was no difference between the 3M. abscessus subspecies. Time-kill assays did not show any bactericidal activity at 4- and 8-fold the MIC. Combination of tedizolid with clarithromycin was synergistic against 1 out of 6 isolates, while indifferent interactions were observed for tedizolid combined with tigecycline, ciprofloxacin, and amikacin.
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-01813096 , version 1 (12-06-2018)

Identifiers

Cite

Fabrice Compain, Daria Soroka, Beate Heym, Jean-Louis Gaillard, Jean-Louis Herrmann, et al.. In vitro activity of tedizolid against the Mycobacterium abscessus complex. Diagnostic Microbiology and Infectious Disease, 2018, 90 (3), pp.186 - 189. ⟨10.1016/j.diagmicrobio.2017.11.001⟩. ⟨inserm-01813096⟩
167 View
1 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More